In Depth Analysis of Albumin Market to Witness a Pronounce Growth During 2016-2023
A recent report by KD market insights titled as "Albumin Market Size, Trends &
Opportunity Outlook – Forecast to 2023" provides the key
trends, opportunities and challenges market will face in the forecasted period
of 6 years i.e. 2016-2023. The study also provides the Albumin Market. competitors share and region
wise analysis around the globe.
Albumin is globular
protein found in blood plasma. Serum albumin is the most abundant plasma
protein, constituting around 50% of human plasma protein. Albumin is obtained
from plasma fractionation process where human serum albumin and bovine serum
albumin is most widely used. Recombinant albumin is produced using recombinant
techniques in rice plants, yeast species, and other cell lines. Albumin is used
as blood volumizer and is employed in the treatment of various diseases
including surgical blood loss, shock, burns, trauma, chronic liver disease,
hypovolemia, hemorrhage, acute liver failure, hypoalbuminemia, and acute
respiratory distress syndrome.
The global albumin
market was valued at $5,381 million in 2016, and is projected to reach
$10,305 million at a CAGR of 9.6% from 2017 to 2023. Increase
in prevalence of rare diseases, shocks, trauma, burns, and other fatalities is
the major factor that contributes toward the growth of the albumin market.
Moreover, other factors that fuel the market growth include increase in
adoption of albumin products, growth in awareness about recombinant albumin
products, and rise in non-therapeutic application of albumin as an excipient
and drug formulating agent. However, stringent governmental regulations and
risks of side effects associated with the use of albumin-based therapy impede
the market growth. Conversely, development of cost-effective therapeutics
through large scale production and high market potential in untapped emerging
economies are expected to provide lucrative growth opportunities for the market.
The global albumin
market is segmented into product, application, and region. Based on
product, the market is divided into human serum albumin, bovine serum albumin,
and recombinant albumin. The applications covered in the study include
therapeutics, drug formulation & vaccine, component of media, and other
applications. Based on region, it is analyzed for North America, Europe,
Asia-Pacific, and LAMEA.
KEY BENEFITS FOR
STAKEHOLDERS
- The study provides an
in-depth analysis of the global albumin market with current trends and future
estimations from 2016 to 2023 to elucidate the imminent investment pockets.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
- Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
- Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
Key market segments:
By Product
- Human Serum Albumin
- Bovine Serum Albumin
- Recombinant Albumin
- Bovine Serum Albumin
- Recombinant Albumin
By Application
- Therapeutics
- Drug Formulation & Vaccine
- Component of Media
- Other Applications
- Drug Formulation & Vaccine
- Component of Media
- Other Applications
By Region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
LIST OF KEY PLAYERS
PROFILED IN THE REPORT
- Grifols, S.A.
- Octapharma AG
- China Biologic Products, Inc.
- Ventria Bioscience
- Shire Plc
- CSL Limited
- Albumedix Ltd.
- Merck KGaA
- Thermo Fisher Scientific
- Baxter International Inc.
- Octapharma AG
- China Biologic Products, Inc.
- Ventria Bioscience
- Shire Plc
- CSL Limited
- Albumedix Ltd.
- Merck KGaA
- Thermo Fisher Scientific
- Baxter International Inc.
LIST OF OTHER PLAYERS
IN THE VALUE CHAIN (These players are not profiled in the report. The same will
be included on request)
- Biotest AG
- Medxbio Pte Ltd
- Mitsubishi Tanabe Pharma Corporation
- Kedrion Biopharma, Inc.
- HiMedia Leading BioSciences Company
- Celgene Corporation
- Medxbio Pte Ltd
- Mitsubishi Tanabe Pharma Corporation
- Kedrion Biopharma, Inc.
- HiMedia Leading BioSciences Company
- Celgene Corporation
Get Complete Research Report
with TOC @: https://www.kdmarketinsights.com/product/albumin-market-amr
Table Of Content:
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and
models
CHAPTER 2: EXECUTIVE
SUMMARY
2.1. Key findings of the
study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and
scope
3.2. Key findings
3.2.1. Top investment
pockets
3.3. Market share
analysis, 2016
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in
prevalence of rare diseases and various life-threatening conditions
3.4.1.2. Increase in
demand for albumin
3.4.1.3. Growing
preferences for recombinant albumin
3.4.1.4. Rise in
non-therapeutic application of albumin
3.4.2. Restraints
3.4.2.1. Stringent
government regulations
3.4.2.2. Risks associated
with albumin
3.4.3. Opportunities
3.4.3.1. Opportunities in
emerging economies
3.4.3.2. Development of
cost effective therapeutics through large scale production
3.4.4. Impact analyses
3.5. Government
regulations
3.6. Patent analysis
(2013-2018)
3.6.1. Patent analysis, by
year
3.6.2. Patent analysis for
year 2017, by country
CHAPTER 4: ALBUMIN
MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and
forecast
4.2. Human serum albumin
4.2.1. Key market trends,
growth factors and opportunities
4.2.2. Market size and
forecast, by region
4.2.3. Market analysis, by
country
4.3. Bovine serum albumin
4.3.1. Key market trends,
growth factors and opportunities
4.3.2. Market size and
forecast, by region
4.3.3. Market analysis, by
country
4.4. Recombinant albumin
4.4.1. Key market trends,
growth factors and opportunities
4.4.2. Market size and
forecast, by region
4.4.3. Market analysis, by
country
CHAPTER 5: ALBUMIN
MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and
forecast (value)
5.2. Therapeutics
5.2.1. Market size and
forecast, by region
5.2.2. Market analysis, by
country
5.3. Drug formulation
& vaccines
5.3.1. Market size and
forecast, by region
5.3.2. Market analysis, by
country
5.4. Component of media
5.4.1. Market size and
forecast, by region
5.4.2. Market analysis, by
country
5.5. Other applications
5.5.1. Market size and
forecast, by region
5.5.2. Market analysis, by
country
CHAPTER 6: ALBUMIN
MARKET, BY REGION
6.1. Overview
6.1.1. Market size and
forecast
6.2. North America
6.2.1. Key market trends,
growth factors and opportunities
6.2.2. North America
albumin market, by country
6.2.2.1. U.S.
6.2.2.1.1. Market size and
forecast, by product
6.2.2.1.2. Market size and
forecast, by application
6.2.2.2. Canada
6.2.2.2.1. Market size and
forecast, by product
6.2.2.2.2. Market size and
forecast, by application
6.2.2.3. Mexico
6.2.2.3.1. Market size and
forecast, by product
6.2.2.3.2. Market size and
forecast, by application
6.2.3. North America
market size and forecast, by product
6.2.4. North America
market size and forecast, by application
6.3. Europe
6.3.1. Key market trends,
growth factors and opportunities
6.3.2. Europe market size
and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Market size and
forecast, by product
6.3.2.1.2. Market size and
forecast, by application
6.3.2.2. France
6.3.2.2.1. Market size and
forecast, by product
6.3.2.2.2. Market size and
forecast, by application
6.3.2.3. UK
6.3.2.3.1. Market size and
forecast, by product
6.3.2.3.2. Market size and
forecast, by application
6.3.2.4. Italy
6.3.2.4.1. Market size and
forecast, by product
6.3.2.4.2. Market size and
forecast, by application
6.3.2.5. Spain
6.3.2.5.1. Market size and
forecast, by product
6.3.2.5.2. Market size and
forecast, by application
6.3.2.6. Rest of Europe
6.3.2.6.1. Market size and
forecast, by product
6.3.2.6.2. Market size and
forecast, by application
6.3.2.6.3. Europe market
size and forecast, by product
6.3.2.6.4. Europe market
size and forecast, by application
6.4. Asia-Pacific
6.4.1. Key market trends,
growth factors and opportunities
6.4.2. Asia-Pacific market
size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Market size and
forecast, by product
6.4.2.1.2. Market size and
forecast, by application
6.4.2.2. China
6.4.2.2.1. Market size and
forecast, by product
6.4.2.2.2. Market size and
forecast, by application
6.4.2.3. India
6.4.2.3.1. Market size and
forecast, by product
6.4.2.3.2. Market size and
forecast, by application
6.4.2.4. Australia
6.4.2.4.1. Market size and
forecast, by product
6.4.2.4.2. Market size and
forecast, by application
6.4.2.5. South Korea
6.4.2.5.1. Market size and
forecast, by product
6.4.2.5.2. Market size and
forecast, by application
6.4.2.6. Rest of
Asia-Pacific
6.4.2.6.1. Market size and
forecast, by product
6.4.2.6.2. Market size and
forecast, by application
6.4.3. Asia-Pacific market
size and forecast, by product
6.4.4. Asia-Pacific market
size and forecast, by application
6.5. LAMEA
6.5.1. Key market trends,
growth factors and opportunities
6.5.2. LAMEA market size
and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Market size and
forecast, by product
6.5.2.1.2. Market size and
forecast, by application
6.5.2.2. Saudi Arabia
6.5.2.2.1. Market size and
forecast, by product
6.5.2.2.2. Market size and
forecast, by application
6.5.2.3. South Africa
6.5.2.3.1. Market size and
forecast, by type
6.5.2.3.2. Market size and
forecast, by application
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Market size and
forecast, by product
6.5.2.4.2. Market size and
forecast, by application
6.5.3. LAMEA market size
and forecast, by product
6.5.4. LAMEA market size
and forecast, by application
Continue:
About Us:
KD Market Insights offers a comprehensive database of syndicated
research studies, customized reports, and consulting services. These reports
are created to help in making smart, instant and crucial decisions based on
extensive and in-depth quantitative information, supported by extensive
analysis and industry insights.
Our dedicated in-house team ensures the reports satisfy the requirement
of the client. We aim at providing value service to our clients. Our reports
are backed by extensive industry coverage and is made sure to give importance
to the specific needs of our clients. The main idea is to enable our clients to
make an informed decision, by keeping them and ourselves up to date with the
latest trends in the market.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
Telephone: +1 (516) 300-1215
Comments
Post a Comment